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ABSTRACT
The use of artiicial intelligence (AI) in patient care can 
offer signiicant beneits. However, there is a lack of 
independent evaluation considering AI in use. The paper 
argues that consideration should be given to how AI will be 
incorporated into clinical processes and services. Human 
factors challenges that are likely to arise at this level 
include cognitive aspects (automation bias and human 
performance), handover and communication between 
clinicians and AI systems, situation awareness and the 
impact on the interaction with patients. Human factors 
research should accompany the development of AI from 
the outset.
INTRODUCTION
The use of artificial intelligence (AI) in 
patient care currently is one of the most 
exciting and controversial topics. It is set to 
become one of the fastest growing indus-
tries, and politicians are putting their weight 
behind this, as much to improve patient 
care as to exploit new economic opportu-
nities. In 2018, the then UK Prime Minister 
pledged that the UK would become one of 
the global leaders in the development of AI 
in healthcare and its widespread use in the 
National Health Service. The Secretary for 
Health and Social Care, Matt Hancock, is a 
self- professed patient registered with Babylon 
Health’s GP at Hand system, which offers 
an AI- driven symptom checker coupled with 
online general practice (GP) consultations 
replacing visits at regular GP clinics.
GP at Hand is, arguably, one of the best- 
known AI- supported services currently in 
use in the UK. It is not without controversy, 
though, and a recent report has found 
evidence that, on average, patients attracted 
to GP at Hand tend to be younger and 
healthier than those at regular GP clinics.1 
This might have significant funding impli-
cations, which as yet have not been properly 
evaluated and understood.
Encouraging results have been achieved 
across a wide range of AI services, in 
particular in domains that rely on pattern 
recognition, classification and prediction. 
Examples include the use of deep neural 
networks (DNNs) to determine whether skin 
lesions are malignant or benign. In an evalu-
ation study, the DNN outperformed doctors 
and achieved accuracy of around 70%.2 
Diabetes is a major public health concern, 
affecting around four million people in the 
UK, and researchers have developed an app 
based on DNNs that can detect changes in 
vascular activity using the light and camera on 
people’s smartphones to determine whether 
a person is likely to suffer from diabetes.3 
Predictive use of DNNs has been demon-
strated in a study that developed an algo-
rithm to support palliative care by predicting 
mortality in the hospital.4 Mental health is 
another area that might benefit significantly 
from the introduction of AI because access 
to mental health professionals remains 
challenging, and the perceived barriers to 
seeking help are frequently high. AI- based 
apps have been developed to deliver cogni-
tive–behavioural therapy. A small, prospec-
tive trial of an AI chatbot found that for a 
limited sample size, the outcomes achieved 
by this app were superior to other forms of 
therapeutic contact.5
While all of these developments provide 
avenues for potentially significant patient 
benefit, it is also timely to take a step back 
and to consider whether it is safe to use AI in 
patient care or, more specifically, what kind 
of evidence is available, and what kinds of 
challenges might have to be addressed. While 
technical challenges, such as the quality of 
training data and the potential introduction 
of bias, have been recognised and discussed,6 
less emphasis has been given so far to 
the impact of integrating AI into clinical 
processes and services. It is at this level, where 
humans and AI come together, that human 
factors challenges are likely to emerge.
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Figure 1 Overview of human factors challenges of using 
artiicial intelligence in patient care.
TECHNOLOGY FOCUS OF EVALUATION STUDIES
Unsurprisingly, many of the published studies on AI in 
patient care focus on the technology itself because devel-
opers are keen to demonstrate that the technology is 
working. It is common to find claims that pit the perfor-
mance of, for example, a DNN against that of clinicians 
at undertaking a well- defined and narrow task. Examples 
include identification of skin cancer,7 identification of 
high- risk breast lesions not requiring surgical excision8 
and detection of diabetic retinopathy.9 These studies have 
shown that AI systems often outperform humans at such 
tasks. However, the evidence base to date remains weak; 
sample sizes are often small; and prospective trials are 
infrequent.10
Compared with the large number of evaluation studies 
undertaken by the developers of AI algorithms, indepen-
dent evaluation studies are relatively infrequent. Where 
there is an independent evaluation, the headline figures 
are not always reproduced. For example, an audit of 23 
patient- facing symptom checkers found that the correct 
diagnosis was listed as the most probable one in only 
around one- third of the test cases.11 There is a step change 
from validating the technology per se to evaluating its use 
in patient care.
Crucially, when delivering patient care, the integra-
tion into clinical systems needs to be considered, but 
prospective trials of AI remain the exception so far. Situ-
ations where the AI system delivers a service by itself 
will be far fewer than scenarios where clinical teams of 
healthcare professionals and AI systems will be cooper-
ating and collaborating to provide patient care. It is likely 
that some of these AI systems will be autonomous agents 
that operate as part of the clinical team. An example is 
the future use of autonomous infusion pumps in inten-
sive care, where the infusion pumps can adjust or stop 
infusions independently.12 Clinicians remain in overall 
charge, but they need to manage and cooperate with these 
autonomous agents. This is not dissimilar to pilots super-
vising flight management systems in modern aircraft, with 
all the human factors issues and perils that recent major 
accidents, such as the Boeing 737 Max, have brought to 
attention.
INTEGRATION OF AI INTO CLINICAL SYSTEMS
When automation started to be deployed at scale in indus-
trial systems, human factors research on ‘automation 
surprises’ and the ‘ironies of automation’ explained some 
of the problems that appeared with the introduction of 
automation.13 14 The fundamental fallacy is the assump-
tion that automation might replace people, but in actual 
reality, the use of automation changes and transforms 
what people do.15 Clinical systems are not necessarily 
comparable to commercial aircraft or autonomous vehi-
cles. However, a look across these different industries can 
be useful to highlight potential human factors challenges 
that are likely to require consideration when adopting AI 
in patient care. The human factors challenges discussed 
further relate to cognitive aspects (automation bias and 
human performance), handover and communication 
between clinicians and AI systems, situation awareness 
and the impact on the interaction with patients (see 
figure 1).
Automation bias
Studies in aviation dating back to the 1980s and 1990s 
and analysis of incident reports recorded in the Aviation 
Safety Reporting System found that pilots frequently 
failed to monitor important flight indicators or did not 
disengage the autopilot and automated flight manage-
ment systems in the cockpit in case of malfunction.16 17 
For example, in 1985, the US National Transportation 
Safety Board (NTSB) investigated an incident involving a 
China Airlines Boeing 747 SP-9 flying from Taipei to Los 
Angeles. When the aircraft was close to San Francisco, an 
engine failed. The autopilot took mitigating actions but 
did not alert the pilots to this problem. The pilots only 
became aware of the engine failure when they disengaged 
the autopilot and the aircraft started rolling over and 
dived into an uncontrolled descent. The NTSB report 
concluded that ‘the probable cause of this accident was 
the captain’s preoccupation with an inflight malfunc-
tion and his failure to monitor properly the airplane’s 
flight instruments […] Contributing to the accident was 
the captain’s over- reliance on the autopilot […]’ (NTSB 
report AAR-86–03).
This phenomenon is referred to as automation bias 
or automation- induced complacency, and represents an 
example of inappropriate decision- making as a result of 
over- reliance on automation.18 Automation bias can lead 
to omission errors, where people do not take a required 
action because the automation failed to alert them, and it 
can lead to errors of commission, where people follow the 
inappropriate advice of an automated system.16
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The speed with which people start to rely and over- 
rely on automation and AI- driven autonomous systems 
might come as a surprise to many as a recent study in the 
automotive domain has demonstrated.19 A sample of 49 
experienced drivers were instructed on the limitations of 
a partially autonomous car and were asked to complete 
a 30 min commute for 1 week. By the end of the week, 
most of the drivers were not watching the road anymore 
and spent instead about 80% of their time on their smart-
phones or reading books and documents.
Healthcare is transitioning towards digital and AI- sup-
ported clinical environments at a rapid pace, and we can 
and should expect clinicians to come to trust and rely on the 
technology. This brings with it the risk of automation bias, 
and this can potentially affect clinician decision- making 
for millions of patients. Automation bias introduced with 
clinical decision support systems has been highlighted in 
a number of studies. An early study comparing the perfor-
mance of radiologists interpreting mammograms found 
that under certain situations, the performance of expert 
radiologists deteriorated when supported by a decision 
support system that highlighted specific areas to focus 
on.20 A study investigating the impact of decision support 
on the accuracy of ECG interpretation found that while 
correct decision support classification increased clinician 
(non- cardiologist) accuracy, incorrect decision support 
classification decreased the accuracy of clinicians from 
56% to 48%.21 Similar findings of the effects of clinical 
decision support were produced by another study looking 
at the impact of clinical decision support in electronic 
prescribing systems.22 The study found that clinical deci-
sion support reduced prescribing errors when working 
correctly but also increased prescribing errors by around 
one- third in cases where the system either did not alert the 
clinician to a potential problem or provided the wrong 
advice. A review of the literature on automation bias in 
healthcare identified six studies investigating the impact 
of automation bias on errors.23 The study concluded that 
task complexity (eg, diagnosis supported by a clinical 
decision support system) and task load (ie, the number of 
task demands) increased the likelihood of over- reliance 
on automation.
Many, if not most, AI systems will be advertised as 
having ultrahigh reliability, and it is to be expected that in 
due course, clinicians will come to rely on these systems. 
However, studies on automation bias suggest that the 
reliability figures by themselves do not allow prediction 
of what will happen in clinical use, when the clinician is 
confronted with a potentially inaccurate system output.20 
How easy or difficult will it be to spot this, and how will 
the potential for automation bias be guarded against?
Impact on human performance
Expertise is built through frequent exposure and 
training. The current generation of human car drivers 
is reasonably skilled in managing complex traffic situ-
ations because many of us do it on an everyday basis. 
Will the generation that has grown up with autonomous 
vehicles have the same levels of basic driving skills that 
enable them to retake control in potentially highly time- 
critical and complex traffic situations when the AI system 
fails? This is particularly relevant in healthcare, where 
healthcare professionals take pride in their professional 
skill sets. Will the expertise of radiographers deteriorate 
when they are exposed only to specific images specifically 
selected by an AI system rather than the broad range of 
images they currently train on day by day?24
Ironically, AI algorithms are frequently trained and 
validated against baseline data developed from human 
performance (eg, radiologist reading of images), and 
the erosion of training opportunities and hands- on skills 
for clinicians as a result of introducing AI systems might 
create a vicious circle where the quality of baseline data 
deteriorates in the long term.
Handover
A key argument for the safety of autonomous vehicles 
is that the driver is able to take control in case of emer-
gencies or unforeseen situations. However, the well- 
publicised fatal Tesla accidents of Josh Brown in 2016 and 
more recently of Jeremy Banner in March 2019 tragically 
demonstrate that drivers do not always take control from 
the autopilot when required. Research has put into ques-
tion whether such an assumption is realistic in the first 
place, considering the short reaction time available.25
Handover is a well- recognised safety critical task in 
the delivery of care, although in traditional concep-
tion, we think of handover between clinicians or teams 
of clinicians.26 In the future, handover between humans 
and autonomous AI systems will become increasingly 
important, and one might assume that this will be even 
more complex than the handover between the autopilot 
and the driver of an autonomous vehicle.
The AI system needs to recognise the need to hand 
over. While this might be achievable, the AI also needs 
to figure out what to hand over, how this should be done 
and when. In human handover, we have recognised the 
need for structured communication protocols to convey 
clearly the salient features of a situation, for example, age, 
time, mechanism, injuries, signs, treatments (ATMIST) 
for emergency care or situation, background, assessment, 
recommendation (SBAR) more generally. Should there 
be an equivalent for human—AI handover?
For example, if an autonomous infusion pump deliv-
ering insulin starts to recognise that it is struggling to 
maintain blood sugar levels, at what point should it trigger 
an alarm to initiate handover? Identifying the precise 
moment requires trading off accuracy with timeliness. 
Should the handover simply convey the infusion pump’s 
inability to maintain blood sugar levels, or should the 
infusion pump provide further information about prior 
adjustments it made? Is the best strategy to wait for the 
infusion pump to trigger an alarm and initiate handover, 
or should we ensure that the clinician is enabled to recog-
nise that a need to retake control will arise?
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These questions are fundamentally about how the AI 
will support clinicians and clinical teams, and how their 
interaction can be optimised.
Situation awareness
Individuals and teams perform more successfully when 
they have good situation awareness.27 Traditional 
handover contributes to the development of shared situa-
tion awareness, and it enables discussion and dialogue.28 
While it might be possible to create autonomous agents 
that have high reliability, questions arise about what the 
autonomous system should communicate to clinicians 
during normal operation to enable the clinician to main-
tain situation awareness. This is not straightforward to 
answer by looking simply at one AI system in isolation, 
because clinicians might be interacting with many auton-
omous agents (eg, multiple infusion pumps) concur-
rently, and the design of communication has to consider 
human information needs and limitations.
Autonomous agents need to build situation awareness, 
too. An autonomous infusion pump needs to know if the 
patient receives other medications that might affect the 
patient’s physiology and response. These medications 
might come via other infusion pumps or they might be 
given by the clinician. The saying ‘if it’s not documented, 
it didn’t happen’ applies here with critical consequence: 
if there are relevant activities going on that are not docu-
mented and communicated to the autonomous agent (eg, 
infusion pump), then as far as the AI is concerned, these 
literally did not happen because the system has no way of 
knowing about it. The results could be catastrophic.
Patient interaction
AI can improve efficiency of clinical processes and free 
up clinician time to undertake other tasks. This is poten-
tially very useful in a pressured health system. However, 
another way of looking at this is that there might be 
smaller numbers of clinicians that have other tasks to do, 
potentially away from the patient. Might AI- enabled inten-
sive care units make do with fewer nurses and therefore 
increase the number of patients per nurse? This might be 
a worry for patients, because they might see less of their 
clinicians, and they might find it harder to provide feed-
back about their care and their condition. For example, 
if a needle comes unstuck, the patient might be aware 
of this before the AI system—and could potentially avoid 
and mitigate any adverse effect—but who do patients 
communicate this to?
Providing healthcare means being responsive to a 
patient’s physiological as well as personal and emotional 
needs. In some clinical settings, such as the intensive care 
unit, the bond between nurse and patient is very strong, 
and for many patients, their episode in intensive care is 
traumatic. How will the introduction of AI and autono-
mous systems in these environments affect this unique 
relationship? It has been argued that AI might actu-
ally create more opportunities for empathy and caring 
because it might allow clinicians to focus more on these 
aspects of care.29 However, whether this is the case, or 
whether the caring aspect is eroded by transforming, for 
example, nursing care into AI specialist nurses who ‘care’ 
for autonomous systems (ie, supervise them), remains to 
be seen.
The introduction of AI at scale has the potential to funda-
mentally change and disrupt communication between 
patients and their clinicians. Will hospitals become 
similar to automated supermarket checkouts, with frus-
trated customers waiting for an overstretched employee 
to attend to the frequent hassles at the checkout? To date, 
these issues have received too little attention compared 
with the focus on accuracy and performance of the AI in 
isolation.
CONCLUSION
The use of AI in patient care is a disrupter of unprec-
edented scale, affecting all areas of the health system. 
Understandably, much effort is devoted to the develop-
ment of the new technologies. However, it is crucially 
important that research around human factors, the 
integration of AI into clinical processes and services, 
and rigorous evaluation studies are not left behind; they 
should accompany and inform the development of these 
exciting innovations from the outset.
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